191 related articles for article (PubMed ID: 34838090)
1. Risk of developing second malignant neoplasms in patients with neuroblastoma: a population study of the US SEER database.
Zhen H; Guan H; Ma J; Wang W; Jing S; Miao Z; Zhang F; Liu Z
Radiat Oncol; 2021 Nov; 16(1):228. PubMed ID: 34838090
[TBL] [Abstract][Full Text] [Related]
2. Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.
Applebaum MA; Henderson TO; Lee SM; Pinto N; Volchenboum SL; Cohn SL
Pediatr Blood Cancer; 2015 Jan; 62(1):128-33. PubMed ID: 25251613
[TBL] [Abstract][Full Text] [Related]
3. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
[TBL] [Abstract][Full Text] [Related]
4. Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study.
Zong X; Pole JD; Grundy PE; Mahmud SM; Parker L; Hung RJ
Eur J Cancer; 2017 Oct; 84():173-183. PubMed ID: 28822326
[TBL] [Abstract][Full Text] [Related]
5. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor.
Lee JS; Padilla B; DuBois SG; Oates A; Boscardin J; Goldsby RE
Pediatr Blood Cancer; 2015 Jul; 62(7):1259-64. PubMed ID: 25809878
[TBL] [Abstract][Full Text] [Related]
6. Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer.
Kushner CJ; Hwang WT; Wang S; Solin LJ; Vapiwala N
Breast Cancer Res Treat; 2018 Jul; 170(1):45-53. PubMed ID: 29488126
[TBL] [Abstract][Full Text] [Related]
7. Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea.
Ju HY; Moon EK; Lim J; Park BK; Shin HY; Won YJ; Park HJ
PLoS One; 2018; 13(11):e0207243. PubMed ID: 30440007
[TBL] [Abstract][Full Text] [Related]
8. Risk of second primary malignancies of adolescent and young adult patients with germ cell cancer: A US population-based analysis.
Jiang S; Jiang H; Sun L; Luo Z
Curr Probl Cancer; 2021 Apr; 45(2):100641. PubMed ID: 32928566
[TBL] [Abstract][Full Text] [Related]
9. Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma.
Federico SM; Allewelt HB; Spunt SL; Hudson MM; Wu J; Billups CA; Jenkins J; Santana VM; Furman WL; McGregor LM
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e6-e12. PubMed ID: 24633303
[TBL] [Abstract][Full Text] [Related]
10. Second Malignant Neoplasms in Patients With Rhabdomyosarcoma.
Zhen H; Liu Z; Guan H; Ma J; Wang W; Shen J; Miao Z; Zhang F
Front Oncol; 2021; 11():757095. PubMed ID: 34722311
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Incidence and Outcomes of Neuroblastoma in Children, Adolescents, and Adults in the United States: A Surveillance, Epidemiology, and End Results (SEER) Program Population Study.
Yan P; Qi F; Bian L; Xu Y; Zhou J; Hu J; Ren L; Li M; Tang W
Med Sci Monit; 2020 Nov; 26():e927218. PubMed ID: 33249420
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and Prognosis of Secondary Lung Cancer in Patients with Primary Nasal Cavity and Sinus Squamous Cell Carcinoma.
Feng J; Jin G; Song X
Adv Ther; 2022 Jun; 39(6):2533-2543. PubMed ID: 35357667
[TBL] [Abstract][Full Text] [Related]
13. Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group.
Breslow NE; Takashima JR; Whitton JA; Moksness J; D'Angio GJ; Green DM
J Clin Oncol; 1995 Aug; 13(8):1851-9. PubMed ID: 7636528
[TBL] [Abstract][Full Text] [Related]
14. Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment.
Rubino C; Adjadj E; Guérin S; Guibout C; Shamsaldin A; Dondon MG; Valteau-Couanet D; Hartmann O; Hawkins M; de Vathaire F
Int J Cancer; 2003 Dec; 107(5):791-6. PubMed ID: 14566829
[TBL] [Abstract][Full Text] [Related]
15. An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors.
Peterson KM; Shao C; McCarter R; MacDonald TJ; Byrne J
Pediatr Blood Cancer; 2006 Jul; 47(1):83-8. PubMed ID: 16317732
[TBL] [Abstract][Full Text] [Related]
16. An Increased Risk of Second Malignant Neoplasms After Rhabdomyosarcoma: Population-Based Evidence for a Cancer Predisposition Syndrome?
Archer NM; Amorim RP; Naves R; Hettmer S; Diller LR; Ribeiro KB; Rodriguez-Galindo C
Pediatr Blood Cancer; 2016 Feb; 63(2):196-201. PubMed ID: 26193998
[TBL] [Abstract][Full Text] [Related]
17. Late causes of death in children treated for CNS malignancies.
Perkins SM; Fei W; Mitra N; Shinohara ET
J Neurooncol; 2013 Oct; 115(1):79-85. PubMed ID: 23828280
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
[TBL] [Abstract][Full Text] [Related]
19. Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence.
Devarahally SR; Severson RK; Chuba P; Thomas R; Bhambhani K; Hamre MR
Pediatr Hematol Oncol; 2003 Dec; 20(8):617-25. PubMed ID: 14578032
[TBL] [Abstract][Full Text] [Related]
20. Subsequent malignancies and their effect on survival in patients with retinoblastoma.
Shinohara ET; DeWees T; Perkins SM
Pediatr Blood Cancer; 2014 Jan; 61(1):116-9. PubMed ID: 23918737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
